Filing Flows › Comparisons › NRXS vs NXL
Neuraxis vs Nexalin Technology: NRXS and NXL compared
Neuraxis is the larger company: $1.9M of revenue in its latest quarter (Q2 2026) against $12K for Nexalin Technology (Q2 2026). Neuraxis is growing faster (+116% against -83% a year earlier).
Where the money goes: NRXS and NXL
Neuraxis (NRXS) · Q2 2026
Neuraxis, Q2 2026: revenue $1.9M (+116% year over year), operating margin -110.2%, net loss $2.1M, operating cash flow −$1.0M. The chart follows the revenue to costs, profit and cash.
Nexalin Technology (NXL) · Q2 2026
Nexalin Technology, Q2 2026: revenue $12K (-83% year over year), net loss $2.2M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
| Neuraxis (NRXS) | Nexalin Technology (NXL) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $1.9M | $12K |
| Revenue growth, Y/Y | +116% | -83% |
| Operating margin | -110.2% | n/m |
| Net earnings | −$2.1M | −$2.2M |
| Net margin | -108.1% | — |
| Operating cash flow | −$1.0M | −$1.8M |
Questions
Which is bigger, Neuraxis or Nexalin Technology?
Neuraxis is the larger company: $1.9M of revenue in its latest quarter (Q2 2026) against $12K for Nexalin Technology (Q2 2026).
Is Neuraxis or Nexalin Technology growing faster?
Neuraxis is growing faster (+116% against -83% a year earlier).
More: Neuraxis earnings · how Neuraxis makes money · Nexalin Technology earnings · how Nexalin Technology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.